Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
25 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Acura Pharmaceuticals Articles
Pfizer updates Acura on Oxecta commercialization plans
17 October 2011
Pfizer and Acura’s tamper resistant opioid Oxecta gets US FDA approval
21 June 2011
Acura slumps 32% after FDA panel fails to back its pain drug Acurox; decision casts doubts over other niacin agents, says Datamonitor
27 April 2010
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth